Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
Sponsor: Mayo Clinic
This NA trial investigates Bone Marrow Failure Syndrome and Clonal Cytopenia of Undetermined Significance and is currently actively recruiting participants. Mayo Clinic leads this study, which shows 15 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
15 versions recorded-
Feb 2026 — Present [monthly]
Recruiting NA
-
Apr 2025 — Feb 2026 [monthly]
Recruiting NA
-
Sep 2024 — Apr 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 10 earlier versions
-
Aug 2023 — May 2024 [monthly]
Recruiting NA
-
Jul 2022 — Aug 2023 [monthly]
Recruiting NA
-
Apr 2022 — Jul 2022 [monthly]
Recruiting NA
-
Apr 2021 — Apr 2022 [monthly]
Recruiting NA
-
Mar 2021 — Apr 2021 [monthly]
Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
-
Feb 2020 — Jan 2021 [monthly]
Recruiting NA
-
Feb 2019 — Feb 2020 [monthly]
Recruiting NA
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .